This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Five years ago, the Covid-19 pandemic swept through the world, resulting in massive disruptions, including to biomedical researchers. As National Institutes of Health-funded physician-scientists, we collectively experienced the pitfalls of lab closures, pauses in clinical trial recruitment due to staffing issues and social distancing policies affecting in-person accrual, and redeployment away from research work to the frontlines to support clinical care.
Nuffield Trust says supply chains have shifted, with drugs for epilepsy and cystic fibrosis among those now scarce Drug shortages in the UK have risen to their worst level for four years, official figures show, with Brexit considered a key reason so many medications are scarce. Drug companies notified the Department of Health and Social Care (DHSC) about disruptions to supply 1,938 times during last year the highest number since the 1,967 seen in 2021.
In a world where innovation, regulation, and consumer behavior shift rapidly, keeping up with pharma news is not just helpfulits essential. For pharma marketing executives and their teams, staying current helps maintain competitive advantage, ensures compliance, and unlocks opportunities for smarter, faster campaign decisions. With new drug approvals, branded marketing trends, and policy updates emerging weekly, how can pharma marketers stay informed without becoming overwhelmed?
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
WASHINGTON — Five days after discovering their 16-year-old son Daniel Puerta unresponsive in bed, Jaime Puerta and his wife decided to discontinue life support as they stood beside him in the Los Angeles Children’s Hospital. Puerta kissed his son’s nose one last time. Daniel, who had no history of drug use, is one of countless stories tragically connected to the nation’s opioid crisis.
Navigating the Complex World of CDMO Contracts: What to Look Out For As a pharmaceutical professional, you're likely no stranger to the importance of finding the right Contract Development and Manufacturing Organization (CDMO) partner. But have you ever stopped to think about the contract itself? A well-crafted CDMO contract can be the difference between a successful partnership and a costly headache.
52
52
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Navigating the Complex World of CDMO Contracts: What to Look Out For As a pharmaceutical professional, you're likely no stranger to the importance of finding the right Contract Development and Manufacturing Organization (CDMO) partner. But have you ever stopped to think about the contract itself? A well-crafted CDMO contract can be the difference between a successful partnership and a costly headache.
By Deborah L. Livornese On Friday, March 21, 2025, FDA announced that it was further delaying the effective date for the ACNU final rule until May 27, 2025. We wrote about the December 26, 2024 publication of the final rule (89 FR 105288) here. Originally, the Nonprescription Drug Product with an Additional Condition for Nonprescription Use (ACNU) final rule was to become effective January 27, 2025.
23andMe said late Sunday it will file for bankruptcy and CEO and co-founder Anne Wojcicki will depart, after she repeatedly tried and failed to take the storied but financially troubled DNA-testing startup private. The company will now try to sell itself through a court-supervised sale. It closed Friday valued at a hair under $50 million, a calamitous fall from 2021, when it went public and soared to a nearly $6 billion market cap.
Peter Wells, CEO of TemperPack, discusses the life sciences industry's shift toward sustainable packaging, particularly in cold chain logistics, to replace outdated petroleum-based materials like expanded polystyrene (EPS). His insights cover the growing importance of sustainability as a business driver, emphasizing efficiency, waste reduction, regulatory pressures, and emerging innovations in biodegradable and recyclable packaging solutions.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Small, early-stage biotech startups are the heart of drug innovation in the U.S. Growing anti-competitive challenges threaten their work, but philanthropy may offer an avenue forward. At the center of these challenges is the U.S. patent system and how it incentivizes anti-competitive behavior among the most powerful players. The argument is that patents — meant to spur innovation — are being gamed by drug manufacturers to extend monopoly profits and exclusivity, stifling competitio
Advances in the life sciences are driving a significant increase in the number of temperature-sensitive pharmaceuticals. The packaging industry is meeting the moment with advances of its own, including high-performance, environmentally-friendly materials that allow life science companies meet stringent thermal requirements and ambitious CO2e reduction goals.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Informa Connects Life Sciences Pricing & Contracting USA May 19-21, 2025 | Philadelphia, PA Drug Channels readers save 10% with code 25DRCH10* Pricing & Contracting USA arrives at an important moment for our industry. As you work to navigate the evolving healthcare landscape, this annual event brings together 60+ expert speakers from 70+ companies to lead the critical discussions that will drive comprehensive market strategy, uniting Medicaid, Policy, Pricing, Contracting & Reporting
How did 23andMe go bankrupt? The same way bankruptcy was described by Ernest Hemingway in 1926: “Two ways: Gradually, and then suddenly.” Since its founding in 2006, the company, which aimed to give consumers access to their genetic information, faced what seemed like one killing blow after another: questions of whether its business was ethical, the Food and Drug Administration blocking the sale of its tests, and, last year, a cyberattack in which hackers gained access to the recor
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so-familiar routine of meetings, deadlines, and messages has returned. But what can you do? There is no pause button to stop the world from spinning. To cope, we are quaffing cups of stimulation. Our choice today is peppermint.
The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
In April 1990, in testimony to the joint congressional hearing titled “Alzheimer’s – The Unmet Challenge for Research and Care,” Hilda Pridgeon, a founder of the Alzheimer’s Association, recounted the challenges of working full-time for Control Data Corporation and caring for her husband, Al, who was living with dementia.
Cadila Pharmaceuticals has launched Cadilose, an advanced Lactulose formulation designed to effectively manage constipation and hepatic encephalopathy (HE). Cadilose is a disaccharide-based osmotic laxative, synthesised from galactose and fructose, which increases water retention in the intestines and promotes smooth bowel movements. It also functions as a prebiotic, encouraging the growth of beneficial gut bacteria.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
297 
Let's personalize your content